Kanaph Therapeutics
Developing next generation therapeutics for oncology and autoimmune diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
$95—143m (Dealroom.co estimates Dec 2023.)
Company register number 6438701092
South Korea (HQ)
Authorizing premium user...